| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 115, 1625-1632, Copyright © 1984 by Endocrine Society
ARTICLES |
LJ Murphy and L Lazarus
The recent observation that adipose conversion of mouse 3T3 fibroblasts is stimulated by physiological concentrations of human GH (hGH) and rat GH in vitro suggested that this cell line may be suitable for the study of GH-receptor interactions. The aim of this study was to examine the binding and subsequent processing of [125I]iodo-hGH by BALB/c 3T3 mouse fibroblasts. Binding of [125I]iodo-hGH to 3T3 fibroblasts was time and temperature dependent. Apparent steady state binding was achieved after 1 and 2 h at 37 and 30 C, respectively. At 37, 30, and 20 C specifically bound [125I]iodo-hGH became increasingly resistant to removal by acid treatment (0.15 M NaCl/0.05 M glycine, pH 2.5). In contrast at 4 C or at higher temperatures in the presence of metabolic inhibitors, a greater proportion of specifically bound hGH was removed by acid treatment. Inclusion of 0.2 mM chloroquine in the incubation medium resulted in significantly more accumulation of trichloroacetic acid (TCA)-precipitable radioactivity compared to control cells without affecting the shift of radioactivity from the acid-elutable to the acid- inaccessible compartment. After removal of [125I]iodo-hGH from the medium there was a rapid loss of radioactivity (t 1/2 = 36.5 +/- 7.2 min, SE, n = 3) from the cell monolayer with a concomitant appearance in the medium of TCA-soluble radioactive species. Chloroquine reduced the rate of efflux of radioactivity from the monolayer (t 1/2 = 4.5 +/- 0.6 h, n = 3) and the appearance of TCA-soluble material in the medium. The half-time of GH receptor loss after inhibition of protein synthesis with cycloheximide (0.1 mM) was 1.25 +/- 0.14 h, n = 3). In contrast half-time of net receptor synthesis calculated from the recovery of specific [125I]iodo-hGH binding capacity after ligand-induced down- regulation was 10.2 +/- 1.5 h, n = 3). These data reveal that after binding of [125I]iodo-hGH to specific cell surface receptors there is rapid irreversible binding of GH to its receptor with a resultant reduction in receptor concentration. Degradation of [125I]iodo-hGH occurs intracellularly and involves processes which are inhibited by lysosomotropic agents. On the basis of these studies we conclude that the binding and subsequent processing of GH by 3T3 fibroblasts is qualitatively similar to that described for other polypeptide hormones and growth factors in this and other cell lines.
This article has been cited by other articles:
![]() |
J. Gent, M. van den Eijnden, P. van Kerkhof, and G. J. Strous Dimerization and Signal Transduction of the Growth Hormone Receptor Mol. Endocrinol., May 1, 2003; 17(5): 967 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gent, P. van Kerkhof, M. Roza, G. Bu, and G. J. Strous Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis PNAS, July 23, 2002; 99(15): 9858 - 9863. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Kerkhof, M. Smeets, and G. J. Strous The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor Endocrinology, April 1, 2002; 143(4): 1243 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Kerkhof, C. M. A. dos Santos, M. Sachse, J. Klumperman, G. Bu, and G. J. Strous Proteasome Inhibitors Block a Late Step in Lysosomal Transport of Selected Membrane but not Soluble Proteins Mol. Biol. Cell, August 1, 2001; 12(8): 2556 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sachse, P. van Kerkhof, G. J. Strous, and J. Klumperman The ubiquitin-dependent endocytosis motif is required for efficient incorporation of growth hormone receptor in clathrin-coated pits, but not clathrin-coated lattices J. Cell Sci., January 11, 2001; 114(21): 3943 - 3952. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Kerkhof, R. Govers, C. M. Alves dos Santos, and G. J. Strous Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent J. Biol. Chem., January 21, 2000; 275(3): 1575 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Strous and R Govers The ubiquitin-proteasome system and endocytosis J. Cell Sci., January 5, 1999; 112(10): 1417 - 1423. [Abstract] [PDF] |
||||
![]() |
C. Jux, K. Leiber, U. Hugel, W. Blum, C. Ohlsson, G. Klaus, and O. Mehls Dexamethasone Impairs Growth Hormone (GH)-Stimulated Growth by Suppression of Local Insulin-Like Growth Factor (IGF)-I Production and Expression of GH- and IGF-I-Receptor in Cultured Rat Chondrocytes Endocrinology, July 1, 1998; 139(7): 3296 - 3305. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Govers, P. van Kerkhof, A. L. Schwartz, and G. J. Strous Di-leucine-mediated Internalization of Ligand by a Truncated Growth Hormone Receptor Is Independent of the Ubiquitin Conjugation System J. Biol. Chem., June 26, 1998; 273(26): 16426 - 16433. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung and K. K. Y. Ho Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4208 - 4213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, M. J. Waters, I. Markus, W. R. Baumbach, and K. K. Y. Ho Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation PNAS, October 14, 1997; 94(21): 11381 - 11386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P.J. King, M.-J. Tseng, C. D. Logsdon, N. Billestrup, and C. Carter-Su Distinct Cytoplasmic Domains of the Growth Hormone Receptor Are Required for Glucocorticoid- and Phorbol Ester-induced Decreases in Growth Hormone (GH) Binding. THESE DOMAINS ARE DIFFERENT FROM THAT REPORTED FOR GH-INDUCED RECEPTOR INTERNALIZATION J. Biol. Chem., July 26, 1996; 271(30): 18088 - 18094. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. A. dos Santos, P. van Kerkhof, and G. J. Strous The Signal Transduction of the Growth Hormone Receptor Is Regulated by the Ubiquitin/Proteasome System and Continues After Endocytosis J. Biol. Chem., March 30, 2001; 276(14): 10839 - 10846. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Alves dos Santos, T. ten Broeke, and G. J. Strous Growth Hormone Receptor Ubiquitination, Endocytosis, and Degradation Are Independent of Signal Transduction via Janus Kinase 2 J. Biol. Chem., August 24, 2001; 276(35): 32635 - 32641. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |